ECSP077240A - Variantes mejoradas de la aprotinina - Google Patents
Variantes mejoradas de la aprotininaInfo
- Publication number
- ECSP077240A ECSP077240A EC2007007240A ECSP077240A ECSP077240A EC SP077240 A ECSP077240 A EC SP077240A EC 2007007240 A EC2007007240 A EC 2007007240A EC SP077240 A ECSP077240 A EC SP077240A EC SP077240 A ECSP077240 A EC SP077240A
- Authority
- EC
- Ecuador
- Prior art keywords
- improved
- proteins
- aprotinin variants
- field
- serine protease
- Prior art date
Links
- 108010039627 Aprotinin Proteins 0.000 title 1
- 229960004405 aprotinin Drugs 0.000 title 1
- ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 102000012479 Serine Proteases Human genes 0.000 abstract 1
- 108010022999 Serine Proteases Proteins 0.000 abstract 1
- 101710102218 Serine protease inhibitor Proteins 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C07K14/8114—Kunitz type inhibitors
- C07K14/8117—Bovine/basic pancreatic trypsin inhibitor (BPTI, aprotinin)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pulmonology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invención se encuadra dentro del campo de proteínas que inhiben la actividad de la serina proteasa. La invención se relaciona asimismo con el campo de construcciones de ácidos nucleicos, vectores y células hospedadoras para la producción de proteínas inhibidoras de la serina proteasa, composiciones farmacéuticas que contienen dichas proteínas y métodos para su uso.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58765504P | 2004-07-13 | 2004-07-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP077240A true ECSP077240A (es) | 2007-03-29 |
Family
ID=35839810
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC2007007240A ECSP077240A (es) | 2004-07-13 | 2007-02-12 | Variantes mejoradas de la aprotinina |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20090005297A1 (es) |
| EP (1) | EP1771464A4 (es) |
| JP (1) | JP2008506391A (es) |
| KR (1) | KR20070041749A (es) |
| CN (1) | CN101014611A (es) |
| AU (1) | AU2005271708A1 (es) |
| BR (1) | BRPI0513267A (es) |
| CA (1) | CA2573368A1 (es) |
| EC (1) | ECSP077240A (es) |
| IL (1) | IL180370A0 (es) |
| MA (1) | MA28779B1 (es) |
| MX (1) | MX2007000473A (es) |
| NO (1) | NO20070640L (es) |
| RU (1) | RU2007105137A (es) |
| WO (1) | WO2006017355A2 (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008110301A1 (de) * | 2007-03-13 | 2008-09-18 | Bayer Schering Pharma Aktiengesellschaft | Aprotinin-varianten mit verbesserten eigenschaften |
| WO2009030464A2 (de) * | 2007-09-08 | 2009-03-12 | Bayer Schering Pharma Aktiengesellschaft | HERSTELLUNG UND VERWENDUNG VON VARIANTEN HUMANER KUNITZ-TYP PROTEASE-INHIBITOREN (hKTPI) |
| CN101412995B (zh) * | 2007-10-17 | 2011-04-06 | 江苏正大天晴药业股份有限公司 | 聚乙二醇修饰的抑肽酶及其制备方法 |
| EP2344201A1 (en) * | 2008-09-17 | 2011-07-20 | Nektar Therapeutics | Oligomer-protease inhibitor conjugates |
| WO2010088547A1 (en) * | 2009-01-29 | 2010-08-05 | Bayer Healthcare Llc | Assays for detecting pegylated blood coagulation factors |
| DE102011013326A1 (de) | 2011-03-08 | 2012-09-13 | Solution Shop Ag | Neue Fibrinolyse-Inhibitoren und deren mdizinische Verwendung |
| IN2014DN08236A (es) * | 2012-03-03 | 2015-05-15 | Immungene Inc | |
| US9605057B1 (en) * | 2013-06-17 | 2017-03-28 | Board Of Regents Of The University Of Texas System | Endotrophin neutralization and use thereof |
| CN108699134A (zh) * | 2015-12-10 | 2018-10-23 | 国家生物技术研究所公司 | 淀粉样β-蛋白前体抑制剂结构域的变体 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0573603T3 (da) * | 1991-03-01 | 2003-10-20 | Dyax Corp | Inhibitorer af human neutrofil elastase og human cathepsin G |
| IL104314A0 (en) * | 1992-01-07 | 1993-05-13 | Novo Nordisk As | Human kunitz-type protease inhibitor and variants thereof,their production and pharmaceutical compositions containing them |
-
2005
- 2005-07-13 KR KR1020077003345A patent/KR20070041749A/ko not_active Withdrawn
- 2005-07-13 BR BRPI0513267-3A patent/BRPI0513267A/pt not_active IP Right Cessation
- 2005-07-13 AU AU2005271708A patent/AU2005271708A1/en not_active Abandoned
- 2005-07-13 CN CNA2005800302602A patent/CN101014611A/zh active Pending
- 2005-07-13 RU RU2007105137/13A patent/RU2007105137A/ru not_active Application Discontinuation
- 2005-07-13 JP JP2007521627A patent/JP2008506391A/ja not_active Withdrawn
- 2005-07-13 WO PCT/US2005/024951 patent/WO2006017355A2/en not_active Ceased
- 2005-07-13 EP EP05791407A patent/EP1771464A4/en not_active Withdrawn
- 2005-07-13 MX MX2007000473A patent/MX2007000473A/es unknown
- 2005-07-13 US US11/659,434 patent/US20090005297A1/en not_active Abandoned
- 2005-07-13 CA CA002573368A patent/CA2573368A1/en not_active Abandoned
-
2006
- 2006-12-26 IL IL180370A patent/IL180370A0/en unknown
-
2007
- 2007-02-01 MA MA29646A patent/MA28779B1/fr unknown
- 2007-02-05 NO NO20070640A patent/NO20070640L/no not_active Application Discontinuation
- 2007-02-12 EC EC2007007240A patent/ECSP077240A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2007105137A (ru) | 2008-08-20 |
| MA28779B1 (fr) | 2007-08-01 |
| AU2005271708A1 (en) | 2006-02-16 |
| MX2007000473A (es) | 2007-03-29 |
| NO20070640L (no) | 2007-04-11 |
| CA2573368A1 (en) | 2006-02-16 |
| EP1771464A4 (en) | 2008-09-03 |
| JP2008506391A (ja) | 2008-03-06 |
| WO2006017355A2 (en) | 2006-02-16 |
| IL180370A0 (en) | 2007-06-03 |
| BRPI0513267A (pt) | 2008-05-06 |
| CN101014611A (zh) | 2007-08-08 |
| EP1771464A2 (en) | 2007-04-11 |
| US20090005297A1 (en) | 2009-01-01 |
| WO2006017355A3 (en) | 2006-12-14 |
| KR20070041749A (ko) | 2007-04-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP077240A (es) | Variantes mejoradas de la aprotinina | |
| BR112016002753A2 (pt) | anticorpos contra o inibidor-1 de ativador de plasminogênio (pai-1) e usos dos mesmos | |
| MX2010001481A (es) | Proteasas fungales acidas. | |
| NO20081013L (no) | 7-substituerte aza-indazoler, sammensetninger inneholdende disse, produksjonsmetode og anvendelse derav | |
| GEP20104974B (en) | Carbonylamino pyrrolopyrazoles, protent kinase inhibitors | |
| EA201391632A1 (ru) | Аминокислотные последовательности, направленные против il-17a, il-17f и/или il-17a/f, и содержащие их полипептиды | |
| NO20071078L (no) | Antivirale forbindelser | |
| ECSP088262A (es) | Proteínas de fusión de albúmina | |
| BR112012015740A2 (pt) | anticorpos de anti-flt3 e metodos de uso dos mesmos | |
| EP2493507A4 (en) | AX213 AND AX132 PCSK9 ANTAGONISTS AND VARIANTS THEREOF | |
| NO20090596L (no) | Antivirale fosfinatforbindelser | |
| EA200901124A1 (ru) | Соединения формулы (i) в качестве ингибиторов серинпротеазы | |
| ECSP10010735A (es) | Compuestos químicos 251 | |
| EA201070247A1 (ru) | Ингибиторы протеасом | |
| CY1110860T1 (el) | Αναστροφη μεταγραφαση τελομερασης πτηνου | |
| GT200600316A (es) | Sales de 4-metilo-n-(3-(4-metilo-imidazol-1-ilo)-5-trifluorometilo-fenilo)-3-(4-piridina-3-ilo-pirimidina-2-iloamino)- benzamida. | |
| MX389888B (es) | Metodos y composiciones relacionados con tioesterasa enzima. | |
| SV2006002513A (es) | Anticuerpos anti-il-6, composiciones, metodos y usos ref. docket cen5094svnp | |
| IN2012DN00801A (es) | ||
| EA201991409A3 (ru) | Антитела к ингибитору активатора плазминогена 1 (pai-1) и пути их применения | |
| DOP2010000134A (es) | Algunos derivados de 2-pirazinona como inhibidores de elastasa de los neutrofilos | |
| MX382624B (es) | Compuestos farmacéuticos. | |
| MY150226A (en) | Novel h5 proteins, nucleic acid molecules and vectors encoding for those, and medicinal use | |
| EA200601562A1 (ru) | Сокристаллы госсипола и их применение | |
| DK1789398T3 (da) | 2-amino-quinazolin derivater anvendelige som inhibitorer af B-sekretase (BACE) |